Seppo Parkkila, MD, PhD, is a professor of anatomy and dean at the Faculty of Medicine and Health Technology, Tampere University, Finland. He graduated (MD) from the University of Oulu in 1991 and obtained a PhD degree in 1994 and a specialist physician degree in Clinical Chemistry in 2001. In 1996–1998, he worked as a visiting researcher at Saint Louis University. In 2002, he was invited to the post of professor of medical technology and biotechnology at the University of Tampere, and in 2008, he was appointed to the post of professor of anatomy. In 2016–2018, Dr. Parkkila served as a vice-rector at the University of Tampere. In 2021, he was a vice-dean for education at the Faculty of Medicine and Health Technology of Tampere University. His research is focused on functional genomics of carbonic anhydrases and pH regulation. He has over 300 publications and an h-index of 60.

Professor Parkkila previously served or currently serves in several academic and other positions, including external evaluator of the EUROXY project (FP6 European Union), coordinator of the DeZnIT project (FP6 European Union), scientific advisor of the METOXIA project (FP7 European Union), advisor of the Alliance4Life project (Horizon 2020, European Union), editorial board member of the Journal of Enzyme Inhibition and Medicinal Chemistry, chairman of the Research Council at the University of Tampere, chairman of the Preparatory Group for Tampere3 research (preparing for a university merger), board member of FinnMedi, Ltd., chairman of the advisory board of the Finnish Medical Foundation, board member of the Pirkanmaa Hospital District (Tampere University Hospital), board member of the University of Tampere Foundation, board member of the UKK Institute, chairman of the FinELib strategy group that promotes open science nationally, and member of the General Synod of the Evangelical Lutheran Church of Finland.